Table II.
Retrospective review of subject demographics at the 11 study sites
Variable | Value | ||
---|---|---|---|
Site subjects, no. | SR only, no.∗ | SR and Mtce, no.† | |
Site location | |||
Fort Carson, Colo | 5 | 5 | 3 |
Jacksonville, Fla | 5 | 5 | 5 |
Fort Gordon, Ga | 17‡ | 16 | 11 |
Fort Campbell, Ky | 4 | 4 | 3 |
Bethesda, Md | 7 | 7 | 5 |
Camp Lejeune, NC | 27 | 27 | 18 |
Fort Bragg, NC | 21‡ | 20 | 20 |
Fort Bliss, Tex | 11 | 11 | 7 |
Fort Hood, Tex | 15 | 15 | 4 |
Fort Sam Houston, Tex | 18‡ | 17 | 17 |
Portsmouth, Va | 7 | 7 | 6 |
Total | 137 | 134 | 99 |
Demographic variables | |||
Asian, no. (%) | 7 (5.1%) | ||
Black/African American, no. (%) | 13 (9.5%) | ||
Hawaiian/Pacific Islander, no. (%) | 3 (2.2%) | ||
White, no. (%) | 74 (54.0%) | ||
Other, no. (%) | 20 (14.6%) | ||
Unknown, no. (%) | 20 (14.6%) | ||
Subject age (y), average (range) | 32.4 (4-64) | ||
Female, no. (%) | 56 (40.9%) | ||
Male, no. (%) | 81 (59.1%) | ||
Concurrent medical conditions, no. (%) | |||
Allergic rhinitis | 47 (34.3%) | ||
Asthma | 13 (9.5%) | ||
Atopic dermatitis | 9 (6.6%) | ||
Chronic urticaria | 8 (5.8%) | ||
Eosinophilic esophagitis | 1 (0.7%) |
Mtce, Maintenance.
Number of subjects who had an SR to IFA.
Number of subjects who had an SR to IFA and reached Mtce with IFA VIT.
Includes patients undergoing IFA VIT who did not have SR to the initial Hymenoptera sting.